KRISTEN JOHNSON: Open Payments
NPI 1861175655 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $81 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $111 |
| GENZYME CORPORATION | 3 | $82 |
| Novo Nordisk Inc | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $21 |
Products named: VOQUEZNA, DUPIXENT, Wegovy, GATTEX, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
